BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...

Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

The firm specialises in high-specification furniture for leading universities including Cambridge and Loughborough, research ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...

There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

The speed advantage that Cerebras offers has drawn clients such as GlaxoSmithKline (GSK), which is exploring AI-driven research agents to enhance drug discovery. In fields such as voice AI, companies ...